Alcohol; chlorhexidine gluconate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for alcohol; chlorhexidine gluconate and what is the scope of freedom to operate?
Alcohol; chlorhexidine gluconate
is the generic ingredient in one branded drug marketed by 3M and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for alcohol; chlorhexidine gluconate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 38 |
DailyMed Link: | alcohol; chlorhexidine gluconate at DailyMed |
Recent Clinical Trials for alcohol; chlorhexidine gluconate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yaneve Fonge | Phase 4 |
Sunnybrook Health Sciences Centre | Phase 4 |
Rafik Batroussy | Phase 2 |
Pharmacology for alcohol; chlorhexidine gluconate
Physiological Effect | Decreased Cell Wall Integrity |
Anatomical Therapeutic Chemical (ATC) Classes for alcohol; chlorhexidine gluconate
US Patents and Regulatory Information for alcohol; chlorhexidine gluconate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | OTC | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for alcohol; chlorhexidine gluconate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | ⤷ Subscribe | ⤷ Subscribe |
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | ⤷ Subscribe | ⤷ Subscribe |
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | ⤷ Subscribe | ⤷ Subscribe |
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | ⤷ Subscribe | ⤷ Subscribe |
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Alcohol; chlorhexidine gluconate Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.